such as a patient with history of heparin-induced thrombocytopenia or antithrombin III deficiency. Fondaparinux may have a role in bridge therapy for these patients. Conclusion. The role of ...
Thus, although the reduced production of most clotting factors in patients with cirrhosis increases the risk of bleeding, the reduced production of proteins C and S and antithrombin, coupled with ...
Efficacy and Bleeding Complications among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes: A Systematic ...
Although low-molecular-weight heparin (LMWH) has been recommended to prevent venous ... The KyberSept trial found that high-dose antithrombin III therapy had no effect on 28-day all-cause mortality in ...
For decades, unfractionated heparin (hereafter, heparin) has been the primary anticoagulant used for extracorporeal membrane oxygenation (ECMO) support. More recently, however, bivalirudin, a direct ...
The existing evidence suggests that low molecular weight heparin (LMWH) has effects beyond its antithrombotic action, improving placental microvessel structure and function of pregnant women with ...
Instituto de Investigaciones Oceanólogicas, Universidad Autónoma de Baja California, Ensenada, Baja California 22830, Mexico ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback